Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Surface Temperature Scanners are Unreliable Fever Detectors

By HospiMedica International staff writers
Posted on 02 Feb 2021
Infrared thermographic screening for Covid‐19 and other febrile infections can result in a large number of false negatives, according to a new study.

Researchers at the University of Portsmouth (United Kingdom) and Jozef Stefan Institute (Ljubljana, Slovenia) conducted a review of literature regarding infrared (IR) thermometers and found that different IR thermometers give different results varying by as much as 2° C, and that more than 80% people tested using IR thermography can give a false negative result, due to a myriad of reasons, such as ambient temperature, infections, sunburn, exercise, and blood pressure. More...
In addition, measuring skin temperature does not give an accurate estimation of deep body temperature.

The researchers suggest therefor, that as a direct measure of deep body temperature is impractical out of the hospital setting, and is also more expensive, overly invasive, and too time consuming for practical widespread use, taking two temperature measurements, one of the finger and the other of the eye, is likely to be a better and more reliable indicator of a fever-induced increase in deep body temperature. The study was published on January 21, 2021, in Experimental Physiology.

“If scanners are not giving an accurate reading, we run the risk of falsely excluding people from places they may want, or need, to go, and we also risk allowing people with the virus to spread the undetected infection they have,” said senior author Professor Michael Tipton, PhD, of the University of Portsmouth. “The pandemic has had a devastating global effect on all aspects of our lives, and unfortunately, it’s unlikely to be the last pandemic we face. It’s critical we develop a method of gauging if an individual has a fever that’s accurate and fast.”

The most common and widespread symptom of COVID-19 is a fever, followed by loss of taste and smell and a host of other symptoms, including dry cough, sputum production, shortness of breath, muscle or joint pain, sore throat, headache chills, nausea or vomiting, nasal congestion, and diarrhea.

Related Links:
University of Portsmouth
Jozef Stefan Institute



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Cardiograph Device
PageWriter TC35
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.